Abstract
O-016 Exploratory analysis of tumor growth rate in patients with advanced gastrointestinal stromal tumors (GIST) treated with regorafenib in the GRID phase 3 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have